Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$52.09 USD
-1.68 (-3.12%)
Updated Sep 23, 2024 03:55 PM ET
After-Market: $52.10 +0.01 (0.02%) 5:22 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-1.26 | -2.67% |
Earnings Summary
For their last quarter, Cytokinetics (CYTK) reported earnings of -$1.31 per share, missing the Zacks Consensus Estimate of -$1.02 per share. This reflects a negative earnings surprise of 28.43%. Look out for CYTK's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$1.26 per share, reflecting a year-over-year increase of 6.67%.
Earnings History
Price & Consensus
Zacks News for CYTK
Cytokinetics (CYTK) Reports Q2 Loss, Lags Revenue Estimates
CYTK: What are Zacks experts saying now?
Zacks Private Portfolio Services